Bdh Industries Ltd. (BSE: 524828) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹241 Cr, it ranks #2,496 by market cap among the 6,197 Indian listed companies on FinBizNet, and #33 of 63 in Pharmaceuticals. At ₹408.15 (as of 16 Nov 2026), the share price is 33.1% below its 52-week high of ₹610.00 and 20.0% above its 52-week low of ₹340.15. The share price is down 5.0% over one year and down 23.9% over three months.
| Current Price | ₹408.15 |
|---|---|
| Market Cap | ₹241 Cr |
| BSE Code | 524828 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 22.3 |
| Return on Equity | 14.84% |
| Return on Assets | 8.74% |
| 52-Week Range | ₹340.15 – ₹610.00 |
| 1-Year Price Change | -5.0% |
| 3-Month Price Change | -23.9% |
| Beta (1Y) | 0.09 |
| Dividend Yield | 1.19% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.bdhind.com |
Delivery averaged 86.1% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally. The company operates through two segments, Pharmaceuticals and Renewable Energy segments. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcers pharmaceutical products. The company also offers antivirals, sedatives/anxiolytics/antidepressants, calcium supplements, cardiovascular products, carminatives/aromatics, corticosteroids, diuretics, drugs acting on uterus, electrolyte replinishers, expextorants, iron supplements, laxatives, local anesthetics, general anesthetics, mydriatics, narcotic-ana
1. Pharmaceuticals-This segment engages in the manufacturing of therapeutic formulations covering a range of pharmaceuticals.
1. Pharmaceuticals-99.1% 2. Renewable Energy-0.9%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹56,531 Cr | 36.3 | 34.46% | ₹1,814 Cr | -8.1% |
| Emcure Pharmaceuticals Ltd | ₹42,344 Cr | 47.9 | 19.57% | ₹2,820 Cr | +73.3% |
| Ajanta Pharma Limited | ₹41,474 Cr | 39.4 | 25.39% | ₹1,794 Cr | +27.8% |
| Piramal Pharma Ltd | ₹32,600 Cr | n/m | -4.00% | ₹2,617 Cr | +22.8% |
| RUBICON RESEARCH LIMITED | ₹28,526 Cr | 112.3 | 19.14% | ₹576 Cr | +162.7% |
| Caplin Point Laboratories Ltdte | ₹18,155 Cr | 28.3 | 19.94% | ₹630 Cr | +23.6% |
| Pfizer Ltd. | ₹17,811 Cr | 24.5 | 17.16% | ₹727 Cr | -24.2% |
| Eris Lifesciences Ltd | ₹17,691 Cr | 28.3 | 18.07% | ₹892 Cr | -17.5% |
| Bdh Industries Ltd. | ₹241 Cr | 22.3 | 14.84% | — | -5.0% |
Listed by market capitalisation. Ratios are shown for context only.
Bdh Industries Ltd. is trading at ₹408.15, with a market capitalisation of ₹241 Cr.
Bdh Industries Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Bdh Industries Ltd. has a P/E of 22.3 and a return on equity of 14.84%.
Bdh Industries Ltd. is listed on the BSE under the scrip code 524828.
Bdh Industries Ltd.'s share price is down 5.0% over one year and down 23.9% over three months. Its 52-week range is ₹340.15 to ₹610.00.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.